FDAnews Drug Daily Bulletin

Pfizer’s Experimental Drug Works in Ulcerative Colitis

Aug. 17, 2012
A A
Pfizer’s experimental rheumatoid arthritis pill tofacitinib eased symptoms of patients with ulcerative colitis, an inflammatory bowel disease that affects 750,000 Americans, a company-sponsored study showed.
Businessweek